Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Opinion and Comment
Nature Biotechnology 26, 27 (1 January 2008) | doi:10.1038/nbt0108-27a
We speak for small biotech
Abstract
I would like to respond to your July editorial, “Who speaks for small biotech?”. As the chair of the Biotechnology Industry Organization's (BIO; Washington, DC) Emerging Companies Section Governing Body, I believe that it is easy to document BIO's deep and enduring commitment to the issues and needs of small biotech companies.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
